Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autism Spectrum Disorder | 30 | 2022 | 374 | 6.540 |
Why?
|
| Autistic Disorder | 24 | 2023 | 345 | 4.620 |
Why?
|
| Chromosomes, Human, Pair 16 | 12 | 2020 | 150 | 2.120 |
Why?
|
| Chromosome Disorders | 8 | 2020 | 310 | 1.390 |
Why?
|
| Child Development Disorders, Pervasive | 7 | 2015 | 82 | 1.280 |
Why?
|
| Parents | 12 | 2023 | 1014 | 1.220 |
Why?
|
| Developmental Disabilities | 8 | 2021 | 695 | 1.140 |
Why?
|
| Chromosome Deletion | 12 | 2020 | 638 | 0.990 |
Why?
|
| Vaccines | 3 | 2020 | 368 | 0.980 |
Why?
|
| Phenotype | 14 | 2020 | 4218 | 0.980 |
Why?
|
| DNA Copy Number Variations | 10 | 2021 | 943 | 0.890 |
Why?
|
| Intellectual Disability | 6 | 2020 | 1043 | 0.810 |
Why?
|
| Chromosome Duplication | 6 | 2020 | 147 | 0.780 |
Why?
|
| Verbal Behavior | 1 | 2020 | 52 | 0.700 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2021 | 814 | 0.690 |
Why?
|
| Child | 44 | 2023 | 24118 | 0.670 |
Why?
|
| Paternal Behavior | 1 | 2019 | 11 | 0.660 |
Why?
|
| Neurosecretory Systems | 1 | 2019 | 23 | 0.660 |
Why?
|
| Maternal Behavior | 1 | 2019 | 65 | 0.640 |
Why?
|
| Heterozygote | 7 | 2021 | 681 | 0.630 |
Why?
|
| Hormones | 1 | 2019 | 189 | 0.620 |
Why?
|
| Sex Characteristics | 1 | 2019 | 308 | 0.570 |
Why?
|
| Intelligence | 5 | 2015 | 98 | 0.540 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2019 | 215 | 0.530 |
Why?
|
| Symbolism | 1 | 2015 | 4 | 0.520 |
Why?
|
| Adolescent | 30 | 2023 | 18984 | 0.500 |
Why?
|
| Patient Advocacy | 1 | 2015 | 62 | 0.500 |
Why?
|
| Vaccination | 3 | 2020 | 946 | 0.470 |
Why?
|
| Child, Preschool | 25 | 2020 | 13840 | 0.460 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2020 | 462 | 0.430 |
Why?
|
| Humans | 57 | 2023 | 122410 | 0.430 |
Why?
|
| Epilepsy, Generalized | 1 | 2023 | 64 | 0.420 |
Why?
|
| Psychotropic Drugs | 2 | 2019 | 125 | 0.400 |
Why?
|
| Social Behavior | 2 | 2015 | 206 | 0.400 |
Why?
|
| Male | 40 | 2023 | 59592 | 0.390 |
Why?
|
| Referral and Consultation | 3 | 2022 | 524 | 0.380 |
Why?
|
| Sequence Deletion | 2 | 2019 | 526 | 0.370 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2021 | 3073 | 0.360 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2020 | 17 | 0.360 |
Why?
|
| Female | 36 | 2023 | 64958 | 0.350 |
Why?
|
| Cognitive Dysfunction | 3 | 2020 | 222 | 0.340 |
Why?
|
| Cognition | 5 | 2020 | 731 | 0.330 |
Why?
|
| Speech Therapy | 1 | 2019 | 7 | 0.330 |
Why?
|
| Neurodegenerative Diseases | 1 | 2012 | 251 | 0.320 |
Why?
|
| Checklist | 1 | 2019 | 87 | 0.320 |
Why?
|
| Occupational Therapy | 1 | 2019 | 36 | 0.320 |
Why?
|
| Family Health | 2 | 2014 | 256 | 0.320 |
Why?
|
| Brain | 2 | 2019 | 2948 | 0.300 |
Why?
|
| Oxytocin | 2 | 2019 | 70 | 0.300 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2017 | 57 | 0.280 |
Why?
|
| Behavior Therapy | 1 | 2019 | 214 | 0.280 |
Why?
|
| Epilepsy | 2 | 2023 | 859 | 0.280 |
Why?
|
| Language | 2 | 2020 | 198 | 0.270 |
Why?
|
| Siblings | 3 | 2020 | 193 | 0.270 |
Why?
|
| Psychometrics | 4 | 2020 | 660 | 0.260 |
Why?
|
| Early Medical Intervention | 1 | 2016 | 29 | 0.260 |
Why?
|
| Self-Injurious Behavior | 1 | 2016 | 64 | 0.250 |
Why?
|
| Sensory Thresholds | 1 | 2015 | 34 | 0.250 |
Why?
|
| Proteins | 1 | 2020 | 1041 | 0.240 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 974 | 0.230 |
Why?
|
| Motion Perception | 1 | 2015 | 71 | 0.230 |
Why?
|
| Models, Neurological | 1 | 2015 | 203 | 0.220 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 188 | 0.220 |
Why?
|
| Adult | 15 | 2021 | 28746 | 0.220 |
Why?
|
| Sibling Relations | 1 | 2012 | 13 | 0.210 |
Why?
|
| Anxiety Disorders | 2 | 2023 | 675 | 0.200 |
Why?
|
| Mixed Function Oxygenases | 1 | 2012 | 34 | 0.200 |
Why?
|
| Genes, X-Linked | 1 | 2012 | 59 | 0.200 |
Why?
|
| Social Adjustment | 1 | 2012 | 84 | 0.200 |
Why?
|
| Carnitine | 1 | 2012 | 78 | 0.190 |
Why?
|
| Neuropsychological Tests | 3 | 2020 | 922 | 0.190 |
Why?
|
| Faculty | 1 | 2012 | 100 | 0.190 |
Why?
|
| Chromosomes, Human, X | 1 | 2012 | 156 | 0.190 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2012 | 104 | 0.180 |
Why?
|
| Consumer Product Safety | 1 | 2010 | 29 | 0.180 |
Why?
|
| Syringomyelia | 1 | 2010 | 17 | 0.180 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 228 | 0.180 |
Why?
|
| Pediatrics | 1 | 2019 | 1140 | 0.170 |
Why?
|
| Speech | 1 | 2020 | 54 | 0.170 |
Why?
|
| Emotions | 1 | 2012 | 363 | 0.170 |
Why?
|
| Prolactin | 1 | 2019 | 104 | 0.160 |
Why?
|
| Arginine Vasopressin | 1 | 2019 | 28 | 0.160 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 70 | 0.160 |
Why?
|
| Young Adult | 7 | 2020 | 8805 | 0.160 |
Why?
|
| Anxiety | 3 | 2023 | 950 | 0.160 |
Why?
|
| Folic Acid | 1 | 2010 | 291 | 0.150 |
Why?
|
| Intelligence Tests | 2 | 2015 | 57 | 0.150 |
Why?
|
| Fixation, Ocular | 1 | 2017 | 16 | 0.150 |
Why?
|
| Chromosome Aberrations | 1 | 2010 | 618 | 0.150 |
Why?
|
| Pattern Recognition, Visual | 1 | 2017 | 24 | 0.150 |
Why?
|
| Telemedicine | 1 | 2023 | 420 | 0.140 |
Why?
|
| Child Behavior | 1 | 2009 | 229 | 0.140 |
Why?
|
| Diseases in Twins | 1 | 2007 | 94 | 0.140 |
Why?
|
| Family | 1 | 2020 | 568 | 0.140 |
Why?
|
| Dietary Supplements | 1 | 2010 | 456 | 0.140 |
Why?
|
| Neural Tube Defects | 1 | 2010 | 351 | 0.140 |
Why?
|
| Language Development Disorders | 2 | 2013 | 173 | 0.140 |
Why?
|
| Choice Behavior | 1 | 2017 | 131 | 0.130 |
Why?
|
| Bayes Theorem | 2 | 2019 | 266 | 0.130 |
Why?
|
| Caregivers | 2 | 2022 | 563 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2020 | 1364 | 0.130 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 804 | 0.130 |
Why?
|
| Aptitude | 1 | 2015 | 12 | 0.130 |
Why?
|
| Pedigree | 4 | 2017 | 1577 | 0.130 |
Why?
|
| Motor Skills | 1 | 2015 | 84 | 0.120 |
Why?
|
| Electronic Health Records | 2 | 2022 | 694 | 0.120 |
Why?
|
| Executive Function | 1 | 2015 | 102 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 139 | 0.120 |
Why?
|
| Gene Duplication | 1 | 2016 | 358 | 0.120 |
Why?
|
| Testosterone | 1 | 2019 | 462 | 0.120 |
Why?
|
| Communication | 2 | 2022 | 505 | 0.120 |
Why?
|
| Mutation | 1 | 2017 | 5786 | 0.110 |
Why?
|
| Aging, Premature | 1 | 2013 | 32 | 0.110 |
Why?
|
| Tetraspanins | 1 | 2013 | 30 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 607 | 0.110 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 54 | 0.110 |
Why?
|
| Schizophrenia | 1 | 2016 | 297 | 0.100 |
Why?
|
| Surveys and Questionnaires | 5 | 2015 | 3613 | 0.100 |
Why?
|
| Memory | 1 | 2015 | 358 | 0.100 |
Why?
|
| Infant | 6 | 2019 | 12347 | 0.100 |
Why?
|
| Neurophysiology | 1 | 2012 | 20 | 0.100 |
Why?
|
| Asperger Syndrome | 3 | 2011 | 7 | 0.100 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1280 | 0.100 |
Why?
|
| Syndrome | 2 | 2020 | 1122 | 0.090 |
Why?
|
| Pediatricians | 1 | 2022 | 65 | 0.090 |
Why?
|
| Middle Aged | 5 | 2020 | 25591 | 0.090 |
Why?
|
| Seizures | 1 | 2016 | 875 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2019 | 3231 | 0.090 |
Why?
|
| Texas | 2 | 2021 | 3513 | 0.090 |
Why?
|
| Information Dissemination | 1 | 2012 | 186 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2006 | 973 | 0.080 |
Why?
|
| Lost to Follow-Up | 1 | 2019 | 31 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2023 | 12036 | 0.080 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 172 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2013 | 804 | 0.080 |
Why?
|
| Neuroimaging | 1 | 2012 | 329 | 0.080 |
Why?
|
| Age of Onset | 2 | 2015 | 580 | 0.080 |
Why?
|
| Base Sequence | 1 | 2013 | 3118 | 0.080 |
Why?
|
| School Health Services | 1 | 2019 | 95 | 0.080 |
Why?
|
| Gene Deletion | 2 | 2021 | 798 | 0.080 |
Why?
|
| Post-Synaptic Density | 1 | 2017 | 11 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 2814 | 0.070 |
Why?
|
| Minority Groups | 1 | 2020 | 250 | 0.070 |
Why?
|
| Genes, Essential | 1 | 2017 | 40 | 0.070 |
Why?
|
| Research Design | 1 | 2020 | 643 | 0.070 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2017 | 125 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2014 | 821 | 0.070 |
Why?
|
| Microarray Analysis | 1 | 2017 | 231 | 0.070 |
Why?
|
| Chickenpox Vaccine | 1 | 2016 | 13 | 0.070 |
Why?
|
| Poliovirus Vaccines | 1 | 2016 | 14 | 0.070 |
Why?
|
| Consensus | 1 | 2019 | 607 | 0.070 |
Why?
|
| Haemophilus Vaccines | 1 | 2016 | 30 | 0.070 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2016 | 13 | 0.070 |
Why?
|
| Hepatitis B Vaccines | 1 | 2016 | 42 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 858 | 0.060 |
Why?
|
| Exons | 2 | 2013 | 793 | 0.060 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2016 | 35 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2012 | 994 | 0.060 |
Why?
|
| Canada | 1 | 2016 | 294 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2021 | 756 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2023 | 15879 | 0.060 |
Why?
|
| North America | 1 | 2015 | 234 | 0.060 |
Why?
|
| Chromatin | 1 | 2017 | 552 | 0.060 |
Why?
|
| Photic Stimulation | 1 | 2015 | 216 | 0.060 |
Why?
|
| Ambulatory Care Facilities | 1 | 2016 | 227 | 0.060 |
Why?
|
| Risk Factors | 3 | 2021 | 9871 | 0.050 |
Why?
|
| Age Factors | 1 | 2019 | 2782 | 0.050 |
Why?
|
| Internal-External Control | 1 | 2012 | 74 | 0.050 |
Why?
|
| Personality Assessment | 1 | 2012 | 104 | 0.050 |
Why?
|
| Penetrance | 1 | 2012 | 102 | 0.050 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2020 | 7 | 0.050 |
Why?
|
| Reference Values | 1 | 2012 | 695 | 0.050 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2020 | 23 | 0.050 |
Why?
|
| Creatine | 1 | 2020 | 41 | 0.040 |
Why?
|
| Interview, Psychological | 1 | 2021 | 96 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2023 | 473 | 0.040 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2020 | 96 | 0.040 |
Why?
|
| Animals | 2 | 2019 | 33888 | 0.040 |
Why?
|
| United States | 2 | 2016 | 10478 | 0.040 |
Why?
|
| Socialization | 1 | 2007 | 16 | 0.040 |
Why?
|
| Twins, Dizygotic | 1 | 2007 | 38 | 0.040 |
Why?
|
| Individuality | 1 | 2007 | 32 | 0.040 |
Why?
|
| Pregnancy | 1 | 2020 | 7102 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2012 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 2007 | 109 | 0.040 |
Why?
|
| Administration, Intranasal | 1 | 2017 | 130 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2009 | 995 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 303 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2006 | 99 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2009 | 1231 | 0.030 |
Why?
|
| Schizophrenic Psychology | 1 | 2016 | 80 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2016 | 159 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2371 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2016 | 126 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 394 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 1561 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 111 | 0.030 |
Why?
|
| Genotype | 1 | 2009 | 2534 | 0.030 |
Why?
|
| Microcephaly | 1 | 2016 | 328 | 0.030 |
Why?
|
| Gene Order | 1 | 2012 | 78 | 0.030 |
Why?
|
| Age Distribution | 1 | 2013 | 400 | 0.030 |
Why?
|
| Cerebellum | 1 | 2016 | 412 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2011 | 88 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 1874 | 0.020 |
Why?
|
| Comorbidity | 1 | 2016 | 1488 | 0.020 |
Why?
|
| Registries | 1 | 2015 | 1378 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3887 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 4987 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4492 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 1759 | 0.020 |
Why?
|
| Mites | 1 | 1986 | 5 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 1412 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1768 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 4649 | 0.020 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 1986 | 73 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 1986 | 319 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3456 | 0.010 |
Why?
|
| Mite Infestations | 1 | 1986 | 5 | 0.000 |
Why?
|
| Wisconsin | 1 | 1986 | 19 | 0.000 |
Why?
|
| Dust | 1 | 1986 | 20 | 0.000 |
Why?
|
| Epidemiologic Methods | 1 | 1986 | 106 | 0.000 |
Why?
|